Lipocine Inc. (NASDAQ:LPCN) went down by -0.36% during the previous trading session, and it is maintaining the win ahead of Thursday’s trading session. The share price of the Biotechnology giant went up by $0.92 to trade ended Thursday trading at $0.92. This is down from the $0.9233 price recorded on Wednesday’s trading session. Its performance from the start of the year has also been positive, with LPCN up by 139.02% year-to-date.
Lipocine Inc. (LPCN) started the day trading at $0.93 and recorded an intraday high of $0.94. It also recorded an intraday low of $0.9004 during Thursday’s trading session. Lipocine Inc. is a very active stock that recorded a trading volume that is less than -187.25% of the average daily trading volume on Thursday. The stock’s trading volume on Thursday was 369013, which is less than -187.25 of the total average daily trading volume of 1.06 million.
Lipocine Inc. (NASDAQ:LPCN) 2020 Performance Impressive
The increase in LPCN’s stock price on Thursday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of LPCN currently stands at $3.45, which is higher than the current trading price of the stock by 73.33%. However, LPCN’s current trading price is -206.67% lower than the 52-week low price of $0.30. In terms of trading volume, Lipocine Inc. currently experienced healthy participation during the last trading session. 369013 shares of Lipocine Inc. were traded on the stock exchange on Thursday, which is less than -187.25% of the 1.06 million average trading volume of the stock.
The performance of the stock has been positive over the past year. LPCN’s performance over the past one year has seen it plunge by -49.45%, while the stock has gone up by 182.82% in the last six months. The quarterly performance of LPCN currently stands at 126.55%, and it is down by -7.07% in the last month. The only positive figure was from the weekly performance, which currently reads 2.22%. At the time of writing LPCN’s report, the company has a total market cap of $45.06M, making it one of the largest publicly-traded companies in the world.Lipocine Inc. also has over 12 employees all over the world.
LPCN Insider Activities
For Lipocine Inc., insiders hold 7.70% of all company shares. The insider transactions over the past six months are up by 17.30%. During that period, insiders bought 260,000 shares in 2 transactions. In that same period, insiders sold 0 of their shares in 0 transactions. After these transactions, insiders at Lipocine Inc. now hold 1.76M shares, which is over 17.76% of the total company stocks. Institutional investors currently hold a large chunk of the LPCN shares, as they control 3.68% of the company’s total stock.
LPCN Fundamental Analysis
For Lipocine Inc., the stock’s diluted earnings per share (EPS) stands at -0.51. In the coming year, analysts expect the EPS to be -0.16. The stock’s EPS growth this year is 8.00%, 20.60% in the previous five years. In terms of revenue, Lipocine Inc.’s quarterly sales (YOY) is shrinking at -0.07, which is lower than the average annual revenue of 20.60% over the past half a decade.
The Return on Investment (ROI) on Lipocine Inc.’s stock currently stands at -96.30%.
LPCN Analysts Prediction
In January 12, 2018, several analysts reiterated their positions on the Lipocine Inc. stock and predicted its performance to their investors. The analysts at H.C. Wainwright believe LPCN is still a Buy and set the price target between $10 and $3. The Canaccord Genuity has a Hold rating for Lipocine Inc., predicting the stock price to stay between $11 and $2.
ROTH Capital and Canaccord Genuity also believe that Lipocine Inc.’s stock is outperforming at the moment.
At the moment, Lipocine Inc.’s Total Debt to Equity ratio stands at 0.97, and they have a long-term Debt to Equity ratio of 0.71.
LPCN Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of LPCN currently stands at 0.10%, while the SMA50 is 26.29%. The biggest one is the SMA200, which is currently reading -17.57% ahead of Thursday’s trading session. The Relative Strength Index of this stock is 58.67.
